A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 620 participants.

Also called NCT06991257

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 620 participants (planned count) (from the registry)
Sponsor
  • Pfizer Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06991257
  • EU CT 2024-518438-94-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Brazil, Bulgaria, Canada, China, Czechia, France, Hungary, Japan, Poland, Puerto Rico, Spain, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06991257. Randomized; quadruple masking; primary purpose treatment. Start 2025-06-19 (actual); primary completion 2028-05-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Condition
Heart Failure
Intervention (Drug)
Placebo
Intervention (Drug)
Low Dose PF-07328948
Intervention (Drug)
Medium Dose PF-07328948
Intervention (Drug)
High Dose PF-07328948
Lead sponsor
Pfizer (class: industry)

Record details

Record id
cardio:ct-nct06991257
Content hash
cccf48bd73e769e4831604c3f5b494198f29653fa6e74aba4c3c3bb032bcefd7